Growth Metrics

Sol-Gel Technologies (SLGL) Shares Outstanding (Weighted Average) (2016 - 2025)

Sol-Gel Technologies (SLGL) reported Shares Outstanding (Weighted Average) of $2.8 million for Q4 2025, little changed year-over-year from $2.8 million in Q4 2024, and little changed on a QoQ basis from $2.8 million in Q3 2025.

Sol-Gel Technologies (SLGL) has 10 years of Shares Outstanding (Weighted Average) data on file, last reported at $2.8 million in Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (changed 0.0% YoY) and the FY2025 annual result came in at $2.8 million, changed 0.0% from the prior year.
  • Shares Outstanding (Weighted Average) held at $2.8 million in Q4 2025 per SLGL's latest filing, from $2.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $27.9 million in Q1 2024 and bottomed at $2.3 million in Q4 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $23.0 million (2021), against an average of $16.7 million.
  • The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) grew 19.59%; it then slumped 90.0% in 2024.
  • Tracing SLGL's Shares Outstanding (Weighted Average) over 5 years: stood at $23.1 million in 2021, then plunged by 89.97% to $2.3 million in 2022, then grew by 17.11% to $2.7 million in 2023, then climbed by 2.85% to $2.8 million in 2024, then increased by 0.0% to $2.8 million in 2025.
  • Per Business Quant, the three latest SLGL Shares Outstanding (Weighted Average) figures stand at $2.8 million (Q4 2025), $2.8 million (Q3 2025), and $2.8 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 177,333.76 Bn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 185,491.37 Bn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 100.00 Bn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 55.66 Bn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 254.10 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - 16.04 Bn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 132.89 Mn
10 Sol-Gel Technologies 205.76 Mn 194.73 Mn - 2.79 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 2.79 Mn
Sep 30, 2025 2.79 Mn
Dec 31, 2024 2.79 Mn
Sep 30, 2024 2.79 Mn
Jun 30, 2024 27.86 Mn
Mar 31, 2024 27.86 Mn
Dec 31, 2023 2.71 Mn
Sep 30, 2023 27.84 Mn
Jun 30, 2023 27.66 Mn
Mar 31, 2023 24.94 Mn
Dec 31, 2022 2.31 Mn
Jun 30, 2022 23.13 Mn
Mar 31, 2022 23.13 Mn
Dec 31, 2021 23.06 Mn
Jun 30, 2021 23.03 Mn
Mar 31, 2021 23.00 Mn
Dec 31, 2020 22.57 Mn
Sep 30, 2020 23.00 Mn
Jun 30, 2020 22.92 Mn
Mar 31, 2020 21.36 Mn
Dec 31, 2019 19.53 Mn
Sep 30, 2019 19.79 Mn
Jun 30, 2019 18.95 Mn
Mar 31, 2019 18.95 Mn
Dec 31, 2018 17.87 Mn
Sep 30, 2018 18.95 Mn
Jun 30, 2018 18.95 Mn
Mar 31, 2018 14.52 Mn
Dec 31, 2017 6.29 Mn
Dec 31, 2016 6.29 Mn